Abstract:Neuritic plaques are pathognomonic and terminal lesions of Alzheimer's Disease (AD). They embody AD pathogenesis because they harbor in one space critical pathologic features of the disease: amyloid deposits, neurofibrillary degeneration (NFD), neuroinflammation, iron accumulation. Neuritic plaques are thought to arise from the conversion of diffuse extracellular deposits of amyloid beta protein (Aβ), and it is believed that during conversion amyloid toxicity creates the dystrophic neurites of neuritic plaques, as well as neurofibrillary tangles (NFTs). However, recent evidence from human post-mortem studies suggests a much different mechanism of neuritic plaque formation where the first step in their creation is neuronal degeneration driven by iron overload and ferroptosis. Similarly, NFTs represent corpses of iron-laden neurons that develop independent of Aβ deposits. In this review, we will focus on the role of free redox-active iron in the development of typical AD pathology, as determined largely by evidence obtained in human temporal lobe during early, preclinical stages of AD. The findings have allowed construction of a scheme of AD pathogenesis where brain iron is center stage and is involved in every step of the sequence of events that produce characteristic AD pathology. We will discuss how the study of preclinical AD has produced a fresh and revised assessment of AD pathogenesis that may be important for reconsidering current therapeutic efforts and guiding future ones. Significance Statement This review offers a novel perspective on AD pathogenesis where elevated brain iron plays a central role and is involved throughout the development of lesions. We review arguments against the amyloid cascade theory and explain how recent findings in humans during early preclinical disease support iron-mediated cell death and endogenous iron containment mechanisms as critical components of neuritic plaque formation and the ensuing dementia.

Ferroptosis in the Pathogenesis of Alzheimer's Disease: The New Evidence for Validation of FAB Model

Insight into the Role of Ferroptosis in Non-neoplastic Neurological Diseases

Ferroptosis as a mechanism of neurodegeneration in Alzheimer's disease

Ferroptosis, a Potential Therapeutic Target in Alzheimer’s Disease

Ferroptosis: A new strategy for targeting Alzheimer's disease

Ferroptosis and Renal Fibrosis: A New Target for the Future (Review)

Ferroptosis in Cognitive Impairment Associated with Diabetes and Alzheimer's Disease: Mechanistic Insights and New Therapeutic Opportunities

Mechanisms of ferroptosis in Alzheimer's disease and therapeutic effects of natural plant products: A review

Iron Dyshomeostasis and Ferroptosis: A New Alzheimer’s Disease Hypothesis?

Ferroptosis and pathogenesis of neuritic plaques in Alzheimer's Disease

Revisiting the intersection of microglial activation and neuroinflammation in Alzheimer's disease from the perspective of ferroptosis

The link between amyloid β and ferroptosis pathway in Alzheimer's disease progression

Ferroptosis: A potential therapeutic target for neurodegenerative diseases

Brain Iron Dyshomeostasis and Ferroptosis in Alzheimer's Disease Pathophysiology: Two Faces of the Same Coin

Implications of liquid-liquid phase separation and ferroptosis in Alzheimer's disease

Inhibition of Ferroptosis Through Regulating Neuronal Calcium Homeostasis: an Emerging Therapeutic Target for Alzheimer’s Disease

Understanding the Mechanism of Ferroptosis in Neurodegenerative Diseases

Research on Ferroptosis as a Therapeutic Target for the Treatment of Neurodegenerative Diseases

A Concise Review on Oxidative Stress-Mediated Ferroptosis and Cuproptosis in Alzheimer's Disease.

The role of ferroptosis in neurodegenerative diseases

Loss of Ferroportin Induces Memory Impairment by Promoting Ferroptosis in Alzheimer's Disease